Erste Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Hold |
11,000
| – | – | 0.01% | 485 |
|
|
2025
Q1 | $1.3M | Hold |
11,000
| – | – | 0.02% | 349 |
|
|
2024
Q4 | $954K | Hold |
11,000
| – | – | 0.01% | 393 |
|
|
2024
Q3 | $986K | Hold |
11,000
| – | – | 0.01% | 386 |
|
|
2024
Q2 | $881K | Hold |
11,000
| – | – | 0.01% | 383 |
|
|
2024
Q1 | $871K | Hold |
11,000
| – | – | 0.01% | 376 |
|
|
2023
Q4 | $876K | Hold |
11,000
| – | – | 0.01% | 376 |
|
|
2023
Q3 | $804K | Hold |
11,000
| – | – | 0.01% | 367 |
|
|
2023
Q2 | $804K | Hold |
11,000
| – | – | 0.01% | 379 |
|
|
2023
Q1 | $666K | Hold |
11,000
| – | – | 0.01% | 399 |
|
|
2022
Q4 | $842K | Buy |
+11,000
| New | +$842K | 0.02% | 377 |
|
|
2022
Q2 | – | Sell |
-11,000
| Closed | -$440K | – | 602 |
|
|
2022
Q1 | $440K | Hold |
11,000
| – | – | 0.01% | 449 |
|
|
2021
Q4 | $391K | Buy |
+11,000
| New | +$391K | 0.01% | 443 |
|
|
2021
Q1 | – | Sell |
-11,500
| Closed | -$946K | – | 530 |
|
|
2020
Q4 | $946K | Hold |
11,500
| – | – | 0.03% | 342 |
|
|
2020
Q3 | $831K | Hold |
11,500
| – | – | 0.03% | 314 |
|
|
2020
Q2 | $878K | Hold |
11,500
| – | – | 0.04% | 301 |
|
|
2020
Q1 | $662K | Buy |
+11,500
| New | +$662K | 0.04% | 286 |
|